Irene McCarthy - President @ Stealth BioTherapeutics

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Primary Job Title President
Primary Organization
Stealth BioTherapeutics

Location Newton Center, Massachusetts, United States
Regions Greater Boston Area, East Coast, New England
Gender Female
Also Known As Reenie

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Irene McCarthy is based out of Newton Center, Massachusetts, and is the President & CEO of Stealth BioTherapeutics. Irene previously worked at InCarda Therapeutics as a Director. Irene McCarthy attended Bates College.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	DNAtriX	Morningside	Yes	Series B - DNAtriX	obfuscated obfuscation
obfuscated obfuscation	Clean Membranes	Morningside	Yes	Series A - Clean Membranes	obfuscated obfuscation

Jobs

Number of Current Jobs

Irene McCarthy

has

current jobs as

CEO

Stealth BioTherapeutics

and

President

Stealth BioTherapeutics

Stealth BioTherapeutics CEO2016
Stealth BioTherapeutics PresidentOct 2015

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Irene McCarthy

is the

Board Member

Biotechnology Innovation Organization

Biotechnology Innovation Organization Board MemberOct 2023

Organization Name	Title At Company	Start Date	End Date
InCarda Therapeutics	Director	Apr 2015	May 2018

Related Hubs

Hub Name	CB Rank (Hub)
Greater Boston Area Companies (Top 10K)	2,548
Therapeutics Companies that Exited	12,572
Greater Boston Area Therapeutics Female Founded Companies	73,625
Therapeutics Companies (Top 10K)	3,015
Northeastern US Biopharma Companies	24,137
New England Companies that Exited	1,298
Pharmaceutical Public Companies With More Than 10 Employees	12,468
Pharmaceutical Companies With Fewer Than 100 Employees (Top 10K)	3,642
New England Biotechnology Companies	18,623
Massachusetts Companies With Less Than $500M in Revenue (Top 10K)	4,396